Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions
1 other identifier
interventional
40
1 country
1
Brief Summary
Forty subjects meeting the inclusion and exclusion criteria were recruited at a single center and signed informed consent forms. Among them, 20 patients in the diffuse group and 20 patients in the localized group were randomly assigned to the conventional radial endobronchial ultrasound combined with cryobiopsy group (conventional group) and the confocal laser endomicroscopy combined with cryobiopsy group (combined group). During the operation, the operator manipulated the bronchoscope to reach the lesion. After confirming the arrival at the lesion using radial endobronchial ultrasound/confocal laser endomicroscopy, cryobiopsy was performed, and the size of the sample was recorded. CBCT scanning was conducted after cryobiopsy. If there was no hole-in-lesion image, cryobiopsy was performed again under CBCT guidance. CBCT scanning was performed after biopsy to determine whether there were any adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2026
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 20, 2026
January 1, 2026
11 months
January 11, 2026
January 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of adverse events
The Incidence of adverse events = (the number of adverse event / the number of procedures) \* 100%
7 days after procedure
Secondary Outcomes (2)
Diagnostic yield
Immediately after the procedure
Hole-in-lesion rate
During the procedure
Study Arms (4)
Diffuse- Conventional Group
ACTIVE COMPARATORThe Diffuse-Conventional Group used conventional cryobiopsy for lung lesions.
Diffuse- Combined Group
EXPERIMENTALThe Diffuse-Combined Group used CLE combined with cryobiopsy for lung lesions
Localized - Convention Group
ACTIVE COMPARATORThe Localized-Conventional Group used conventional cryobiopsy for lung lesions.
Localized - Combined Group
EXPERIMENTALThe Localized-Combined Group used CLE combined with cryobiopsy for lung lesions
Interventions
Patients in the conventional group will underg cryobiopsy for lung lesions.
Patients in the combined group will undergo CLT combined with cryobiopsy for lung lesions.
Eligibility Criteria
You may qualify if:
- Patients over 18 years old with lung lesions indicated by chest CT;
- Preoperative CT indicates that the lung lesion to be biopsied has a bronchus leading to it;
- Able to understand and voluntarily sign the written informed consent form. -
You may not qualify if:
- Patients with contraindications to anesthesia or bronchoscopy;
- Patients with uncorrectable coagulation disorders;
- Patients who cannot discontinue therapeutic anticoagulants within an appropriate time interval before surgery;
- Patients with severe liver or kidney dysfunction, mental illness, etc.;
- Pregnant or lactating patients;
- Patients without a clear histological or clinical diagnosis;
- Subjects deemed unsuitable for participation in this study by the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163
Guangzhou, Guangdong, 510100, China
Related Publications (3)
Kramer T, Wijmans L, de Bruin M, van Leeuwen T, Radonic T, Bonta P, Annema JT. Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer. Thorax. 2022 Apr;77(4):370-377. doi: 10.1136/thoraxjnl-2021-216885. Epub 2021 Jun 25.
PMID: 34172559BACKGROUNDWellikoff AS, Holladay RC, Downie GH, Chaudoir CS, Brandi L, Turbat-Herrera EA. Comparison of in vivo probe-based confocal laser endomicroscopy with histopathology in lung cancer: A move toward optical biopsy. Respirology. 2015 Aug;20(6):967-74. doi: 10.1111/resp.12578. Epub 2015 Jun 19.
PMID: 26094505BACKGROUNDSorokina A, Danilevskaya O, Averyanov A, Zabozlaev F, Sazonov D, Yarmus L, Lee HJ. Comparative study of ex vivo probe-based confocal laser endomicroscopy and light microscopy in lung cancer diagnostics. Respirology. 2014 Aug;19(6):907-13. doi: 10.1111/resp.12326. Epub 2014 Jun 9.
PMID: 24909555BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
January 11, 2026
First Posted
January 20, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 20, 2026
Record last verified: 2026-01